Table 2.
Frequency of Treatment Related Adverse Events and Laboratory Abnormalities.
| Event | Any Grade | Grade ≥ 3 |
|---|---|---|
| Any event – no. (%) | 41 (100) | 14 (34) |
| Any serious event – no. (%) | 1 (2) | 1 (2) |
| Most common events – no. (%) | ||
| Fatigue | 24 (59) | 1 (2) |
| Nausea | 21 (51) | 0 |
| Anorexia | 10 (24) | 0 |
| Diarrhea | 9 (22) | 1 (2) |
| Vomiting | 9 (22) | 0 |
| Peripheral sensory neuropathy | 6 (15) | 1 (2) |
| Laboratory Abnormalities – no. (%) | ||
| Anemia | 19 (46) | 2 (5) |
| Neutrophil count decrease | 16 (39) | 8 (20) |
| Lymphocyte count decrease | 12 (29) | 4 (10) |
| Platelet count decreased | 13 (32) | 2 (5) |
| White blood cell count decreased | 10 (24) | 3 (7) |
| Alkaline phosphatase increased | 6 (15) | 0 |
AE with > 10% incidence